As some experts and long-COVID sufferers call for antivirals to be more accessible, others say the science isn't proven yet
Some long COVID sufferers are paying thousands of dollars for COVID-19 antivirals, hoping they will lessen their symptoms during reinfections. While some experts say it's time to allow more Australia access to subsidised medications, others say more research is needed.
ABC News ·